Can D-Wave Hold Its Own Against 2 Fast-Growing Rivals?

D-Wave Quantum is facing increased competitive pressure as larger tech firms including Intel and IBM expand their push into quantum computing through new investments and partnerships. The article frames Q2 2026 as a more challenging environment for pure-play quantum names, with size and operational scale becoming a key advantage for incumbents. The tone is cautious and mildly negative for D-Wave, though the piece is more thematic than event-driven.

Analysis

QBTS is the most exposed name because this is a scale-and-distribution story more than a pure technology story at this point. When larger incumbents lean in, the key risk is not immediate product displacement but customer decision paralysis: enterprise buyers slow pilots, demand more proof-of-uptime, and wait for procurement-friendly bundled offerings from bigger vendors. That tends to hit smaller pure plays first through longer sales cycles and lower conversion rates, so the stock can underperform even if headline market size is expanding.

The second-order winner is less obvious: INTC and IBM can use quantum as an adjacencies play, monetizing it through existing cloud, consulting, and enterprise relationships rather than standalone hardware economics. That means their upside is optionality-rich but low-capex, while QBTS bears the burden of proving unit economics, not just technical milestones. If the market starts valuing quantum like a platform distribution war rather than a scientific race, multiple compression for smaller names can arrive months before any true commercial displacement.

The near-term setup is more about sentiment than fundamentals. QBTS likely remains vulnerable over the next 1-3 months to any headline that reinforces “incumbents are catching up,” especially if broader risk appetite fades and investors rotate out of pre-profitability innovation names. The contrarian angle is that this competitive pressure could actually validate the category and expand the total addressable market faster than expected, so the selloff may be overdone if we see evidence of enterprise demand surviving the noise.

Key Decisions for Investors

• Short QBTS vs long IBM in a pair trade over the next 4-8 weeks: express the view that enterprise distribution and services leverage will outperform a standalone pure play if quantum spending stays experimental rather than revenue-accretive.
• If long QBTS already, use a collar into the next 30-45 days: buy downside protection with a 10-15% out-of-the-money put and finance with a 12-18% out-of-the-money call to stay exposed to an upside partnership headline while limiting multiple-compression risk.
• Add INTC on weakness only if the market is discounting quantum too literally: treat it as a low-cost optionality position, with a 6-12 month horizon and a thesis that the stock can benefit from ecosystem positioning even without near-term earnings contribution.